EpiGentek Group Inc., 110 Bi County Boulevard, Suite 122, Farmingdale, NY, 11735, United States of America.
EpiGentek Group Inc., 110 Bi County Boulevard, Suite 122, Farmingdale, NY, 11735, United States of America.
Immunol Lett. 2022 Feb;242:1-7. doi: 10.1016/j.imlet.2022.01.002. Epub 2022 Jan 7.
SARS-CoV-2 harbors a unique S1/S2 furin cleavage site within its spike protein, which can be cleaved by furin and other proprotein convertases. Proteolytic activation of SARS-CoV-2 spike protein at the S1/S2 boundary facilitates interaction with host ACE2 receptor for cell entry. To address this, high titer antibody was generated against the SARS-CoV-2-specific furin motif. Using a series of innovative ELISA-based assays, this furin site blocking antibody displayed high sensitivity and specificity for the S1/S2 furin cleavage site, including with a P681R mutation, and demonstrated effective blockage of both enzyme-mediated cleavage and spike-ACE2 interaction. The results suggest that immunological blocking of the furin cleavage site may afford a suitable approach to stem proteolytic activation of SARS-CoV-2 spike protein and curtail viral infectivity.
SARS-CoV-2 在其刺突蛋白中具有独特的 S1/S2 弗林裂解位点,该位点可被弗林和其他蛋白前体转化酶切割。SARS-CoV-2 刺突蛋白在 S1/S2 边界处的蛋白水解激活有助于与宿主 ACE2 受体相互作用以进入细胞。为了解决这个问题,针对 SARS-CoV-2 特异性弗林基序产生了高滴度的抗体。使用一系列创新的基于 ELISA 的测定法,该弗林位点阻断抗体对 S1/S2 弗林裂解位点表现出高灵敏度和特异性,包括 P681R 突变,并有效阻断了酶介导的裂解和刺突-ACE2 相互作用。结果表明,免疫阻断弗林裂解位点可能提供一种合适的方法来阻止 SARS-CoV-2 刺突蛋白的蛋白水解激活并减少病毒感染力。